Cargando…

A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO

PURPOSE: Extracorporeal Membrane Oxygenation (ECMO) has been utilized as salvage therapy in patients with acute respiratory distress syndrome (ARDS) secondary to COVID-19. We aim to present our experience with ECMO in a community hospital for minority patients with COVID-19. METHODS: This is a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Quesada, C. Tejera, Chen, K., Reddy, R., Grajeda, E., Dayanand, P., Sabates, A., Ghumman, W., Chait, R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979395/
http://dx.doi.org/10.1016/j.healun.2021.01.1122
_version_ 1783667275435343872
author Quesada, C. Tejera
Chen, K.
Reddy, R.
Grajeda, E.
Dayanand, P.
Sabates, A.
Ghumman, W.
Chait, R.
author_facet Quesada, C. Tejera
Chen, K.
Reddy, R.
Grajeda, E.
Dayanand, P.
Sabates, A.
Ghumman, W.
Chait, R.
author_sort Quesada, C. Tejera
collection PubMed
description PURPOSE: Extracorporeal Membrane Oxygenation (ECMO) has been utilized as salvage therapy in patients with acute respiratory distress syndrome (ARDS) secondary to COVID-19. We aim to present our experience with ECMO in a community hospital for minority patients with COVID-19. METHODS: This is a retrospective analysis of all SARS-CoV2 infected patients who developed ARDS and received ECMO at a tertiary cardiovascular care center between March and August 2020. Patient demographics, data pre- and on-ECMO, hemodynamics, and ventilation parameters were collected. Primary outcome of interest was mortality. Secondary outcomes were length of stay, bleeding requiring transfusion, coagulopathies, infections, and procedural-related complications. RESULTS: We identified 10 COVID-19 patients with ARDS treated with ECMO. The mean age was 45 years and 70% were male. The racial composition of the patients consisted of Blacks (30%) and Hispanics (70%). Comorbidities included hypertension (40%), diabetes mellitus (50%), and hyperlipidemia (20%). Eight patients were treated with VV-ECMO, and the remaining patients with VA-ECMO. Hospital-acquired infections including ventilator-associated pneumonia and bacteremia were reported in 50% and 30%, respectively. Hemorrhage requiring transfusion was reported in all 10 patients, with 60% of patients having bleeding from a gastrointestinal source. 70% of patients developed thrombocytopenia, and 20% developed a clot within the ECMO circuit. Coagulation disorders reported, included heparin-induced thrombocytopenia (20%), deep vein thrombosis (30%), and pulmonary embolism (20%). 90% of patients died, and 1 patient was discharged to a long-term acute care hospital (See Table 1 for outcomes). CONCLUSION: Despite using ECMO as rescue therapy, mortality among COVID-19 patients who developed ARDS remained high in minority groups. Further studies are needed to investigate management of COVID-19 related complications.
format Online
Article
Text
id pubmed-7979395
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-79793952021-03-23 A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO Quesada, C. Tejera Chen, K. Reddy, R. Grajeda, E. Dayanand, P. Sabates, A. Ghumman, W. Chait, R. J Heart Lung Transplant 1005 PURPOSE: Extracorporeal Membrane Oxygenation (ECMO) has been utilized as salvage therapy in patients with acute respiratory distress syndrome (ARDS) secondary to COVID-19. We aim to present our experience with ECMO in a community hospital for minority patients with COVID-19. METHODS: This is a retrospective analysis of all SARS-CoV2 infected patients who developed ARDS and received ECMO at a tertiary cardiovascular care center between March and August 2020. Patient demographics, data pre- and on-ECMO, hemodynamics, and ventilation parameters were collected. Primary outcome of interest was mortality. Secondary outcomes were length of stay, bleeding requiring transfusion, coagulopathies, infections, and procedural-related complications. RESULTS: We identified 10 COVID-19 patients with ARDS treated with ECMO. The mean age was 45 years and 70% were male. The racial composition of the patients consisted of Blacks (30%) and Hispanics (70%). Comorbidities included hypertension (40%), diabetes mellitus (50%), and hyperlipidemia (20%). Eight patients were treated with VV-ECMO, and the remaining patients with VA-ECMO. Hospital-acquired infections including ventilator-associated pneumonia and bacteremia were reported in 50% and 30%, respectively. Hemorrhage requiring transfusion was reported in all 10 patients, with 60% of patients having bleeding from a gastrointestinal source. 70% of patients developed thrombocytopenia, and 20% developed a clot within the ECMO circuit. Coagulation disorders reported, included heparin-induced thrombocytopenia (20%), deep vein thrombosis (30%), and pulmonary embolism (20%). 90% of patients died, and 1 patient was discharged to a long-term acute care hospital (See Table 1 for outcomes). CONCLUSION: Despite using ECMO as rescue therapy, mortality among COVID-19 patients who developed ARDS remained high in minority groups. Further studies are needed to investigate management of COVID-19 related complications. Published by Elsevier Inc. 2021-04 2021-03-20 /pmc/articles/PMC7979395/ http://dx.doi.org/10.1016/j.healun.2021.01.1122 Text en Copyright © 2021 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 1005
Quesada, C. Tejera
Chen, K.
Reddy, R.
Grajeda, E.
Dayanand, P.
Sabates, A.
Ghumman, W.
Chait, R.
A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
title A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
title_full A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
title_fullStr A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
title_full_unstemmed A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
title_short A Case Series of Black and Hispanic COVID-19 Patients Treated with ECMO
title_sort case series of black and hispanic covid-19 patients treated with ecmo
topic 1005
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979395/
http://dx.doi.org/10.1016/j.healun.2021.01.1122
work_keys_str_mv AT quesadactejera acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT chenk acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT reddyr acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT grajedae acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT dayanandp acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT sabatesa acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT ghummanw acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT chaitr acaseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT quesadactejera caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT chenk caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT reddyr caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT grajedae caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT dayanandp caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT sabatesa caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT ghummanw caseseriesofblackandhispaniccovid19patientstreatedwithecmo
AT chaitr caseseriesofblackandhispaniccovid19patientstreatedwithecmo